Business Context and Reporting Period
Guardian Pharmacy Services, Inc. (GRDN) filed a Form 8-K on September 10, 2026, reporting the execution of common stock lock-up agreements. The company is incorporated in Delaware and trades on the New York Stock Exchange.
Key Financial Metrics
This filing is a current report regarding corporate governance and equity structure. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
- Lock-Up Agreements: The Company entered into agreements with founders, executive officers, and certain employees (Lock-Up Holders) effective September 10, 2026.
- Shares Restricted: Approximately 29.9 million shares of Class A common stock are subject to the lock-up, representing about 81% of the shares held by insiders prior to the IPO.
- Restriction Period: Holders are restricted from selling or transferring these shares without prior consent until September 14, 2027.
- Capital Structure Update: Following the automatic conversion of the final tranche of Class B common stock on September 27, 2026, the Company will have 63,320,300 shares of Class A common stock outstanding.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on operations, or specific risk factors beyond the standard disclosure of the lock-up agreement terms. The primary contingency noted is the upcoming conversion of 13,521,396 Class B shares to Class A shares on September 27, 2026.
Key Facts for Investor Verification
- Verify the exact number of shares outstanding (63,320,300) post-conversion on September 27, 2026.
- Confirm the lock-up expiration date of September 14, 2027, for approximately 29.9 million insider shares.
- Review the specific "limited exceptions" to the lock-up agreement that may allow for early transfers.
- Monitor the impact of the Class B to Class A conversion on the total share count and potential dilution.